Suspension of trading

Income Statement Exscientia plc

Stocks

EXAI

US30223G1022

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2024-11-19 EST			5-day change	1st Jan Change
4.840 ^USD	+3.20%		-.--%	-

24-11-20	Exscientia plc(NasdaqGS:EXAI) dropped from S&P Global BMI Index	CI
24-11-20	Recursion Pharmaceuticals, Exscientia Complete Business Combination	MT

9a2caf420ed33852f751e700.VztRI9LYM10rX7zZVoYi_c_qPUhYH6Sle18Km21DtO8.Pmg4TbCLdz5SNfSLYex6u_areiEySdLiQiw6qxx2zIo1SgB8pqhbFWRt2w

Published financial data: EXSCIENTIA PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	9.11M	9.67M	27.36M	27.22M	20.08M
Total Revenues	9.11M	9.67M	27.36M	27.22M	20.08M
Cost of Goods Sold, Total	5.63M	14.23M	17.11M	33.3M	27.4M
Gross Profit	3.47M	-4.55M	10.25M	-6.07M	-7.32M
Selling General & Admin Expenses, Total	5.51M	8.92M	24.59M	38.42M	45.33M
R&D Expenses	6.67M	10.92M	44.05M	129M	128M
Other Operating Expenses	-534K	-1.2M	-3.75M	-5.74M	-6.64M
Other Operating Expenses, Total	11.65M	18.64M	64.88M	162M	167M
Operating Income	-8.18M	-23.19M	-54.64M	-168M	-174M
Interest Expense, Total	-50K	-86K	-167K	-328K	-1.04M
Interest And Investment Income	272K	110K	26K	5.68M	16.63M
Net Interest Expenses	222K	24K	-141K	5.35M	15.58M
Income (Loss) On Equity Invest.	-90K	-1.21M	-1.15M	-691K	-1.64M
Currency Exchange Gains (Loss)	-	-	938K	22.32M	-1.54M
Other Non Operating Income (Expenses)	-	-3K	-2K	-6K	-24K
EBT, Excl. Unusual Items	-8.04M	-24.38M	-54.99M	-141M	-162M
Merger & Related Restructuring Charges	-	-	-1.2M	-	-
EBT, Incl. Unusual Items	-8.04M	-24.38M	-56.19M	-141M	-162M
Income Tax Expense	-1.73M	-2.1M	-6.96M	-21.91M	-16.12M
Earnings From Continuing Operations	-6.32M	-22.28M	-49.23M	-119M	-146M
Net Income to Company	-6.32M	-22.28M	-49.23M	-119M	-146M
Net Income - (IS)	-6.32M	-22.28M	-49.23M	-119M	-146M
Net Income to Common Incl Extra Items	-6.32M	-22.28M	-49.23M	-119M	-146M
Net Income to Common Excl. Extra Items	-6.32M	-22.28M	-49.23M	-119M	-146M
Per Share Items
Net EPS - Basic	-0.06	-0.22	-0.99	-0.97	-1.18
Basic EPS - Continuing Operations	-0.06	-0.22	-0.99	-0.97	-1.18
Basic Weighted Average Shares Outstanding	99.11M	102M	49.88M	122M	124M
Net EPS - Diluted	-0.06	-0.22	-0.99	-0.97	-1.18
Diluted EPS - Continuing Operations	-0.06	-0.22	-0.99	-0.97	-1.18
Diluted Weighted Average Shares Outstanding	99.11M	102M	49.88M	122M	124M
Normalized Basic EPS	-0.05	-0.15	-0.69	-0.72	-0.82
Normalized Diluted EPS	-0.05	-0.15	-0.69	-0.72	-0.82
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	-7.79M	-22.57M	-51.31M	-160M	-163M
EBITA	-8.16M	-23.17M	-52.74M	-163M	-170M
EBIT	-8.18M	-23.19M	-54.64M	-168M	-174M
EBITDAR	-7.72M	-22.56M	-51.22M	-159M	-162M
Effective Tax Rate - (Ratio)	21.47	8.6	12.39	15.58	9.95
Current Domestic Taxes	-1.73M	-2.1M	-	-	-
Total Current Taxes	-1.73M	-2.1M	-6.68M	-20.47M	-15.26M
Deferred Foreign Taxes	-	-	-279K	-1.44M	-869K
Total Deferred Taxes	-	-	-279K	-1.44M	-869K
Normalized Net Income	-5.03M	-15.24M	-34.37M	-87.9M	-101M
Interest on Long-Term Debt	50K	86K	167K	328K	1.04M
Supplemental Operating Expense Items
General and Administrative Expenses	5.44M	8.91M	24.49M	38.01M	45.04M
Research And Development Expense From Footnotes	6.67M	10.92M	44.05M	137M	134M
Net Rental Expense, Total	68K	11K	93K	409K	286K
Imputed Operating Lease Interest Expense	-	3.33K	28.85K	113K	145K
Imputed Operating Lease Depreciation	-	7.67K	64.15K	296K	141K
Stock-Based Comp., Other (Total)	711K	2.07M	10.47M	30.58M	24.35M
Total Stock-Based Compensation	711K	2.07M	10.47M	30.58M	24.35M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	31.45M	62.58M	562M	405M	259M
Short Term Investments	-	-	-	101M	104M
Total Cash And Short Term Investments	31.45M	62.58M	562M	506M	363M
Accounts Receivable, Total	2.01M	589K	1.49M	699K	3.37M
Other Receivables	3.64M	4.14M	14.61M	41.53M	32.56M
Total Receivables	5.64M	4.73M	16.1M	42.23M	35.93M
Inventory	-	-	359K	50K	-
Prepaid Expenses	503K	1.62M	3.15M	5.94M	5.96M
Total Current Assets	37.6M	68.94M	582M	554M	405M
Gross Property Plant And Equipment	3.79M	10.01M	17.83M	61.09M	88.16M
Accumulated Depreciation	-616K	-1.66M	-3.94M	-8.64M	-20.69M
Net Property Plant And Equipment	3.18M	8.35M	13.89M	52.44M	67.47M
Long-term Investments	360K	123K	2.57M	2.14M	2.32M
Goodwill	173K	173K	5.98M	6.32M	6.19M
Other Intangibles, Total	159K	139K	36.33M	33.6M	28.46M
Deferred Tax Assets Long-Term	-	-	-	1.01M	690K
Other Long-Term Assets, Total	-	-	100K	100K	663K
Total Assets	41.47M	77.72M	641M	650M	511M
Liabilities
Accounts Payable, Total	2.21M	3.33M	6.29M	30.74M	11.34M
Accrued Expenses, Total	689K	1.49M	7.47M	18.63M	22.14M
Current Portion of Leases	227K	677K	1.08M	2.64M	2.4M
Current Income Taxes Payable	-	2K	6K	10K	111K
Unearned Revenue Current, Total	12.58M	9.04M	29.96M	29.43M	25.04M
Other Current Liabilities	313K	98K	931K	10.19M	4.06M
Total Current Liabilities	16.02M	14.64M	45.74M	91.65M	65.07M
Long-Term Debt	-	-	296K	313K	306K
Long-Term Leases	885K	2.76M	3.8M	10.94M	16.22M
Unearned Revenue Non Current	2.51M	1.26M	16.36M	58.45M	65.47M
Deferred Tax Liability Non Current	-	-	7.12M	7.07M	5.77M
Other Non Current Liabilities	-	535K	537K	2.34M	2.16M
Total Liabilities	19.42M	19.2M	73.85M	171M	155M
Common Stock, Total	-	-	60K	61K	63K
Additional Paid In Capital	32.32M	89.1M	365M	365M	365M
Retained Earnings	-12.14M	-34.05M	136M	23.11M	-110M
Comprehensive Income and Other	1.88M	3.48M	66.29M	91.11M	101M
Total Common Equity	22.05M	58.52M	567M	479M	356M
Total Equity	22.05M	58.52M	567M	479M	356M
Total Liabilities And Equity	41.47M	77.72M	641M	650M	511M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	99.11M	102M	121M	123M	126M
ECS Total Common Shares Outstanding	99.11M	102M	121M	123M	126M
Book Value / Share	0.22	0.57	4.69	3.89	2.83
Tangible Book Value	21.72M	58.21M	524M	439M	321M
Tangible Book Value Per Share	0.22	0.57	4.34	3.57	2.55
Total Debt	1.11M	3.44M	5.18M	13.9M	18.92M
Net Debt	-30.34M	-59.15M	-557M	-492M	-344M
Debt Equivalent Oper. Leases	544K	88K	744K	3.27M	2.29M
Equity Method Investments, Total	360K	123K	424K	-	173K
Account Code - Inventory Valuation	-	3	3	-	3
Inventories - Raw Materials, Total	-	-	-	15K	-
Inventories - Work In Process, Total	-	-	359K	35K	-
Machinery, Total	1.37M	2.54M	7.23M	14.78M	30.53M
Full Time Employees	-	-	285	481	483

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-6.32M	-22.28M	-49.23M	-119M	-146M
Depreciation & Amortization - CF	555K	1.04M	2.28M	4.84M	10.9M
Amortization of Goodwill and Intangible Assets - (CF)	15K	15K	1.89M	4.63M	4.62M
Depreciation & Amortization, Total	570K	1.06M	4.17M	9.46M	15.51M
Amortization of Deferred Charges, Total - (CF)	4K	8K	11K	19K	55K
Asset Writedown & Restructuring Costs	-	-	-	-	1.31M
(Income) Loss On Equity Investments - (CF)	90K	1.21M	1.15M	691K	1.64M
Stock-Based Compensation (CF)	711K	2.07M	10.47M	30.58M	24.35M
Other Operating Activities, Total	-2.24M	193K	-11.57M	-53.89M	6.54M
Change In Accounts Receivable	-1.98M	1.55M	-574K	666K	-5.35M
Change In Inventories	-	-	-184K	309K	50K
Change In Accounts Payable	-47K	1.06M	2.7M	17.29M	-14.34M
Change in Unearned Revenues	15.09M	-4.78M	35.72M	51.66M	-5.51M
Change in Other Net Operating Assets	1.15M	-1.52M	631K	1.43M	4.1M
Cash from Operations	7.02M	-21.43M	-6.7M	-60.52M	-118M
Capital Expenditure	-1.53M	-2.36M	-5.65M	-22.39M	-26.46M
Cash Acquisitions	-	-	-18.04M	-	-
Sale (Purchase) of Intangible assets	-172K	-3K	-1.46M	-53K	-200K
Investment in Marketable and Equity Securities, Total	-	-1.38M	-1.42M	-100M	5.15M
Cash from Investing	-1.7M	-3.74M	-26.57M	-123M	-21.51M
Long-Term Debt Repaid, Total	-162K	-470K	-881K	-1.74M	-3.19M
Total Debt Repaid	-162K	-470K	-881K	-1.74M	-3.19M
Issuance of Common Stock	16K	56.78M	534M	24K	38K
Repurchase of Common Stock	-	-	-	-2.28M	-243K
Cash from Financing	-146K	56.31M	533M	-4M	-3.4M
Foreign Exchange Rate Adjustments	-4K	-3K	-91K	29.6M	-2.6M
Net Change in Cash	5.18M	31.13M	500M	-158M	-145M
Supplemental Items
Cash Interest Paid	-	-	19K	29K	15K
Cash Income Tax Paid (Refund)	-114K	-3.21M	-309K	-3.17M	-29.18M
Levered Free Cash Flow	-	-15.81M	-9.28M	-71.6M	-116M
Unlevered Free Cash Flow	-	-15.76M	-9.17M	-71.39M	-116M
Change In Net Working Capital	-	2.04M	-17.43M	-15.75M	20.01M
Net Debt Issued / Repaid	-162K	-470K	-881K	-1.74M	-3.19M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-	-24.32	-9.51	-16.24	-18.79
Return on Total Capital	-	-34.05	-10.77	-19.68	-25.14
Return On Equity %	-	-55.31	-15.75	-22.71	-34.98
Return on Common Equity	-	-55.31	-15.75	-22.71	-34.98
Margin Analysis
Gross Profit Margin %	38.14	-47.08	37.45	-22.31	-36.48
SG&A Margin	60.52	92.26	89.86	141.12	225.76
EBITDA Margin %	-85.55	-233.36	-187.55	-587.35	-809.39
EBITA Margin %	-89.61	-239.6	-192.79	-598.71	-845.89
EBIT Margin %	-89.78	-239.75	-199.7	-615.7	-868.88
Income From Continuing Operations Margin %	-69.36	-230.39	-179.94	-436.13	-726.94
Net Income Margin %	-69.36	-230.39	-179.94	-436.13	-726.94
Net Avail. For Common Margin %	-69.36	-230.39	-179.94	-436.13	-726.94
Normalized Net Income Margin	-55.2	-157.54	-125.63	-322.88	-504.53
Levered Free Cash Flow Margin	-	-163.48	-33.9	-262.99	-579.9
Unlevered Free Cash Flow Margin	-	-162.93	-33.52	-262.24	-576.65
Asset Turnover
Asset Turnover	-	0.16	0.08	0.04	0.03
Fixed Assets Turnover	-	1.68	2.46	0.82	0.33
Receivables Turnover (Average Receivables)	-	7.45	26.27	24.83	9.86
Inventory Turnover (Average Inventory)	-	-	-	162.82	-
Short Term Liquidity
Current Ratio	2.35	4.71	12.72	6.05	6.22
Quick Ratio	2.32	4.6	12.64	5.98	6.13
Operating Cash Flow to Current Liabilities	0.44	-1.46	-0.15	-0.66	-1.81
Days Sales Outstanding (Average Receivables)	-	49.14	13.89	14.7	37
Days Outstanding Inventory (Average Inventory)	-	-	-	2.24	-
Average Days Payable Outstanding	-	71.35	-	204.86	-
Cash Conversion Cycle (Average Days)	-	-	-	-187.92	-
Long Term Solvency
Total Debt/Equity	5.04	5.87	0.91	2.9	5.32
Total Debt / Total Capital	4.8	5.55	0.9	2.82	5.05
LT Debt/Equity	4.01	4.72	0.72	2.35	4.65
Long-Term Debt / Total Capital	3.82	4.46	0.72	2.28	4.41
Total Liabilities / Total Assets	46.82	24.7	11.53	26.29	30.35
EBIT / Interest Expense	-163.52	-269.64	-327.17	-511.02	-167.27
EBITDA / Interest Expense	-152.12	-257.35	-302.19	-482.16	-152.4
(EBITDA - Capex) / Interest Expense	-182.66	-284.84	-335.99	-550.41	-177.76
Total Debt / EBITDA	-0.15	-0.16	-0.1	-0.09	-0.12
Net Debt / EBITDA	3.99	2.67	11.04	3.11	2.16
Total Debt / (EBITDA - Capex)	-0.12	-0.14	-0.09	-0.08	-0.1
Net Debt / (EBITDA - Capex)	3.32	2.41	9.93	2.72	1.86
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	6.2	182.87	-0.5	-26.24
Gross Profit, 1 Yr. Growth %	-	-231.13	-325.01	-159.28	20.58
EBITDA, 1 Yr. Growth %	-	189.71	163.02	211.61	1.64
EBITA, 1 Yr. Growth %	-	183.96	162.26	209.01	4.21
EBIT, 1 Yr. Growth %	-	183.62	171.46	206.78	4.09
Earnings From Cont. Operations, 1 Yr. Growth %	-	252.75	120.94	141.17	22.94
Net Income, 1 Yr. Growth %	-	252.75	120.94	141.17	22.94
Normalized Net Income, 1 Yr. Growth %	-	203.07	125.58	155.73	15.25
Diluted EPS Before Extra, 1 Yr. Growth %	-	243	35.45	-1.5	20.88
Accounts Receivable, 1 Yr. Growth %	-	-70.67	153.65	-53.21	382.4
Inventory, 1 Yr. Growth %	-	-	-	-86.07	-
Net Property, Plant and Equip., 1 Yr. Growth %	-	163.04	66.32	277.44	28.65
Total Assets, 1 Yr. Growth %	-	87.43	724.28	1.4	-21.38
Tangible Book Value, 1 Yr. Growth %	-	167.98	801.03	-16.31	-26.85
Common Equity, 1 Yr. Growth %	-	165.36	868.53	-15.51	-25.72
Cash From Operations, 1 Yr. Growth %	-	-405.1	-68.73	802.8	94.34
Capital Expenditures, 1 Yr. Growth %	-	54.81	138.83	296.49	18.19
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-33.26	671.87	62.63
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-33.76	678.42	62.19
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	73.33	67.77	-14.33
Gross Profit, 2 Yr. CAGR %	-	-	71.77	15.49	-15.46
EBITDA, 2 Yr. CAGR %	-	-	170.5	186.34	75.94
EBITA, 2 Yr. CAGR %	-	-	167.28	184.73	77.46
EBIT, 2 Yr. CAGR %	-	-	171.69	188.58	76.77
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	179.17	130.83	72.19
Net Income, 2 Yr. CAGR %	-	-	179.17	130.83	72.19
Normalized Net Income, 2 Yr. CAGR %	-	-	161.47	140.18	69.84
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	115.54	15.5	9.12
Accounts Receivable, 2 Yr. CAGR %	-	-	-13.74	8.94	50.23
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	109.16	150.55	120.36
Total Assets, 2 Yr. CAGR %	-	-	293.06	189.11	-10.72
Tangible Book Value, 2 Yr. CAGR %	-	-	391.39	174.6	-21.76
Common Equity, 2 Yr. CAGR %	-	-	406.96	186.05	-20.78
Cash From Operations, 2 Yr. CAGR %	-	-	-2.32	68.03	318.86
Capital Expenditures, 2 Yr. CAGR %	-	-	92.29	207.73	116.48
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	126.97	240.83
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	127.08	241.66
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	44.05	27.57
Gross Profit, 3 Yr. CAGR %	-	-	-	20.48	17.16
EBITDA, 3 Yr. CAGR %	-	-	-	183.56	102.74
EBITA, 3 Yr. CAGR %	-	-	-	180.53	103.67
EBIT, 3 Yr. CAGR %	-	-	-	182.91	105.42
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	165.88	87.11
Net Income, 3 Yr. CAGR %	-	-	-	165.88	87.11
Normalized Net Income, 3 Yr. CAGR %	-	-	-	159.54	88.04
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	66.02	17.27
Accounts Receivable, 3 Yr. CAGR %	-	-	-	-29.65	78.89
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	154.64	100.63
Total Assets, 3 Yr. CAGR %	-	-	-	150.22	87.3
Tangible Book Value, 3 Yr. CAGR %	-	-	-	172.38	76.69
Common Equity, 3 Yr. CAGR %	-	-	-	178.98	82.5
Cash From Operations, 3 Yr. CAGR %	-	-	-	104.99	76.38
Capital Expenditures, 3 Yr. CAGR %	-	-	-	144.74	123.68
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	103.1
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	102.98